+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Target | Von Hippel-Lindau Disease Tumor Suppressor (VHL) |
Clonality | Polyclonal |
Reactivity | Rat |
Tested Applications | ELISA, IHC |
Host | Rabbit |
Recommended dilutions | IHC: 1/50 - 1/500. Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Immunogen | Histone-lysine N-methyltransferase EZH2 |
Isotype | IgG |
Form | Liquid |
Purity | ≥ 95% (SDS-PAGE) |
Purification | Purified by immunogen affinity chromatography. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Validity | 12 months. |
UniProt Primary AC | P40337 (UniProt, ExPASy) |
UniProt Secondary AC | B2RE45, Q13599, Q6PDA9 |
UniProt Entry Name | VHL_HUMAN |
Gene Symbol | VHL |
GeneID | 7428 |
OMIM | 144700 |
HGNC | 12687 |
KEGG | hsa:7428 |
Ensembl | ENSG00000134086 |
String | 9606.ENSP00000256474 |
Molecular Weight | Observed MW: 20 kDa |
Buffer | PBS, pH 7.3, with 0.02% sodium azide and 50% glycerol. |
Concentration | 2 mg/ml |
Availability | Shipped within 5-12 working days. |
Note | This product is for research use only. |